Pathophysiology of Metastatic Bone Disease and the Role of the Second Generation of Bisphosphonates: From Basic Science to Medicine

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|11|1546-1557

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.11, 2016-03, pp. : 1546-1557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

State of the Art of Biochemical Markers in Metastatic Bone Disease and the Role of Bisphosphonates as Therapeutic Agents

By  

Current Pharmaceutical Analysis, Vol. 1, Iss. 3, 2005-11 ,pp. : 225-241

Bentham Science Publishers

Access to resources Recommend Favorite

Combined Therapies of Bone Disease with Bisphosphonates

By  

Current Pharmaceutical Design, Vol. 16, Iss. 27, 2010-09 ,pp. : 2988-2997

Bentham Science Publishers

Access to resources Recommend Favorite

Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 7, 2009-01 ,pp. : 854-870

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of the Calcium-Sensing Receptor in Bone Biology and Pathophysiology

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 3, 2009-04 ,pp. : 289-301

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease

By Dawson Nancy A  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 705-716

Informa Healthcare

Access to resources Recommend Favorite